HCPLive | The preeminent online destination for tools, techniques, and information for healthcare professionals | Conference 360

This year's Annual San Antonio Breast Cancer Symposium is the first to be presented by the CTRC, AACR, and the Baylor College of Medicine, and thus encompasses "the full spectrum of breast cancer research and facilitate the rapid transition of new knowledge into improved care for breast cancer patients." Our editors are covering the best of the 2008 SABCS and creating several session recaps each day, to be are posted on HCPLive.com.

Day 4:

Alternating Mammography and MRI for Breast Cancer Detection

Accuracy of Oncotype DX Confirmed for Patients with Early Stage Breast Cancer Treated with Aromatase Inhibitors

Assessing Breast Cancer Risk with Genetics

Predictive Models of 15-year Survival Developed Based on Reliable Data

Day 3:

Tolerability and Adherence to Hormonal Therapy Difficult to Asses in Patients with Early Breast Cancer

Non Anthracycline-containing Regimen HER TC Safe for Lower Risk Early Breast Cancer Patients

Researchers Identify Specific Associations Between Cancer Risk and Breast Density

Effects of Aromatase Inhibitors and Tamoxifen on Coagulation Factors

Day 2:

Early Breast Cancer Patients Live Longer on Sequencing Tamoxifen and Anastrozole Versus 5 Years of Tamoxifen

Communicating Risk Prediction of Breast Cancer for an Individual Woman an Elusive Goal

Significant Increased Recurrence Rates Among Breast Cancer Patients with HER2-positive, T1a,bN0M0 Tumors

Meta-analysis Finds Aromatase Inhibitors Decrease Rates of Cancer Recurrence and Death Compared with Tamoxifen

Day 1:

Adjuvant Therapy with Letrozole Improves Disease-Free Survival for Some Women with Early Stage Breast Cancer



Advertisement